Company intelligence / Profile preview

Primaxis Technology Ventures

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Primaxis Technology Ventures was a Toronto-based venture capital firm that specialized in early-stage investments within the life sciences and physical sciences sectors. The firm primarily focused on seed and Series A funding for Canadian companies emerging from academic and research institutions. Its investment portfolio heavily featured biotechnology, medical device, and healthcare information technology startups. Notable companies previously backed by Primaxis include Trillium Therapeutics and Viventia Biotech. The firm played a significant role in the Ontario innovation ecosystem before winding down its active investment operations.

Industry: Investors

Beyond the preview

Go deeper on Primaxis Technology Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primaxis Technology Ventures.

Explore the full profile